The burden of antimicrobial resistance among urinary tract isolates of Escherichia coli in the United States in 2017
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The burden of antimicrobial resistance among urinary tract isolates of Escherichia coli in the United States in 2017
Authors
Keywords
-
Journal
PLoS One
Volume 14, Issue 12, Pages e0220265
Publisher
Public Library of Science (PLoS)
Online
2019-12-11
DOI
10.1371/journal.pone.0220265
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Application of Next-Generation Sequencing for Characterization of Surveillance and Clinical Trial Isolates: Analysis of the Distribution of β-lactamase Resistance Genes and Lineage Background in the United States
- (2019) Rodrigo E Mendes et al. Open Forum Infectious Diseases
- Comparative Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Enterobacteriaceae Isolates Producing Extended-Spectrum β-Lactamases from United States Hospitals
- (2019) Mariana Castanheira et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Uropathogenic Escherichia coli Subclone ST131-H30 Is Responsible for Most Antibiotic Prescription Errors at an Urgent Care Clinic
- (2018) Veronika Tchesnokova et al. CLINICAL INFECTIOUS DISEASES
- Effect of outpatient antibiotics for urinary tract infections on antimicrobial resistance among commensal Enterobacteriaceae : a multinational prospective cohort study
- (2018) A.J. Stewardson et al. CLINICAL MICROBIOLOGY AND INFECTION
- Fluoroquinolones for urinary tract infection and within-household spread of resistant Enterobacteriaceae: the smoking gun
- (2018) Barbara W. Trautner CLINICAL MICROBIOLOGY AND INFECTION
- Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae
- (2018) Jesús Rodríguez-Baño et al. CLINICAL MICROBIOLOGY REVIEWS
- Experiences in fosfomycin susceptibility testing and resistance mechanism determination in Escherichia coli from urinary tract infections in the UK
- (2018) Jennifer L. Cottell et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Multi-drug-resistant Gram-negative bacteria causing urinary tract infections: a review
- (2017) Annarita Mazzariol et al. JOURNAL OF CHEMOTHERAPY
- The Pandemic H30 Subclone of Sequence Type 131 (ST131) as the Leading Cause of Multidrug-Resistant Escherichia coli Infections in the United States (2011–2012)
- (2017) James R. Johnson et al. Open Forum Infectious Diseases
- Fluoroquinolone and Third-Generation-Cephalosporin Resistance among Hospitalized Patients with Urinary Tract Infections Due to Escherichia coli: Do Rates Vary by Hospital Characteristics and Geographic Region?
- (2016) Monique R. Bidell et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial Activities of Ceftazidime-Avibactam and Comparator Agents against Gram-Negative Organisms Isolated from Patients with Urinary Tract Infections in U.S. Medical Centers, 2012 to 2014
- (2016) Helio S. Sader et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The PandemicH30 Subclone ofEscherichia coliSequence Type 131 Is Associated With Persistent Infections and Adverse Outcomes Independent From Its Multidrug Resistance and Associations With Compromised Hosts
- (2016) James R. Johnson et al. CLINICAL INFECTIOUS DISEASES
- The clinical impact of ST131 H30-Rx subclone in urinary tract infections due to multidrug-resistant Escherichia coli
- (2016) Fusun Can et al. Journal of Global Antimicrobial Resistance
- Emerging Escherichia coli O25b/ST131 Clone Predicts Treatment Failure in Urinary Tract Infections
- (2014) F. Can et al. CLINICAL INFECTIOUS DISEASES
- Global dissemination of a multidrug resistant Escherichia coli clone
- (2014) N. K. Petty et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Contemporary Diversity of β-Lactamases among Enterobacteriaceae in the Nine U.S. Census Regions and Ceftazidime-Avibactam Activity Tested against Isolates Producing the Most Prevalent β-Lactamase Groups
- (2013) Mariana Castanheira et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial Susceptibility of Inpatient Urinary Tract Isolates of Gram-Negative Bacilli in the United States: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) Program: 2009−2011
- (2013) Sam K. Bouchillon et al. CLINICAL THERAPEUTICS
- Trends in Klebsiella pneumoniae carbapenemase-positive K. pneumoniae in US hospitals: report from the 2007–2009 SENTRY Antimicrobial Surveillance Program
- (2013) Robyn M. Kaiser et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Characterization of Escherichia coli Isolates from Hospital Inpatients or Outpatients with Urinary Tract Infection
- (2013) F. Toval et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Positively selected FimH residues enhance virulence during urinary tract infection by altering FimH conformation
- (2013) D. J. Schwartz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The CTX-M-15-Producing Escherichia coli Clone O25b: H4-ST131 Has High Intestine Colonization and Urinary Tract Infection Abilities
- (2012) Sophie Vimont et al. PLoS One
- International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases
- (2011) Kalpana Gupta et al. CLINICAL INFECTIOUS DISEASES
- Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
- (2008) Johann DD Pitout et al. LANCET INFECTIOUS DISEASES
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started